The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Fri., Mar. 5, 5:31 PM

Slide #9. Moleculin Biotech, Inc. (NASDAQ:MBRX) 1 for 6 Reverse Split

Announced: 1/29/2021
Stock Split: 1 for 6
Record Date: 1/29/2021
Pay Date: 2/1/2021
MBRX Optionable?: No

Moleculin Biotech is a pharmaceutical company focused on the treatment of resistant cancers. Co.'s technologies are based on discoveries made at MD Anderson Cancer Center (MD Anderson). Co.'s primary product candidates is Annamycin, for which Food and Drug Administration allowed an Investigational New Drug Application to go into effect for a Phase 1/2 trial for the treatment of relapsed or refractory acute myeloid leukemia. Co. also has a license agreement with MD Anderson pursuant to which Co. had been granted a license for the patent and technology rights related to its WP1066 Portfolio and its close analogs, molecules targeting the modulation of primary oncogenic transcription factors.
MBRX Detailed Information Page & Split History »

Company Name: 
Moleculin Biotech Inc
Drugs & Pharmaceuticals
Number of ETFs Holding MBRX: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the MBRX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
87th percentile
(ranked higher than approx. 87% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.